查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086957

高強度聚焦超音波（HIFU）：市場洞察、競爭格局與市場預測（2034 年）

High-Intensity Focused Ultrasound - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

高強度聚焦超音波市場概述

概述：

  • 高強度聚焦超音波（HIFU）市場預計在2025年達到14.5億美元，預計到2034年將達到30.5億美元。這一成長是由癌症發病率上升、對非侵入性和手術治療的需求增加以及在前列腺癌、神經病學、子宮肌瘤和美容領域不斷擴大的臨床應用所驅動的。
  • 全球高強度聚焦超音波（HIFU）市場預計在 2026 年至 2034 年的預測期內將以 8.6% 的複合年成長率成長。
  • 按應用領域分類，腫瘤學領域預計將成為市場的主要驅動力，到 2025 年將佔高強度聚焦超音波(HIFU) 市場佔有率的 52%。
  • 就引導技術而言，預計到 2025 年，超音波引導 HIFU 細分市場將佔 58% 的市場佔有率，從而推動高強度聚焦超音波市場的發展。
  • 就治療方法而言，預計到 2025 年，非侵入性治療將引領市場，佔高強度聚焦超音波(HIFU) 市場佔有率的 74%。
  • 按最終用戶分類，預計到 2025 年，醫院領域將引領市場，佔高強度聚焦超音波市場的 43% 佔有率。
  • 預計到 2025 年，北美將以 41% 的銷售額引領全球高強度聚焦超音波市場，在全球區域市場佔有率中佔據最高地位。

高強度聚焦超音波（HIFU）是一種非侵入性、非手術治療技術，它將超音波能量集中於體內深處的目標部位，提高組織溫度，從而在保護周圍組織的同時，精準地去除病變組織。在超音波影像或磁振造影（MRI）的即時引導下，HIFU無需切口或電離輻射即可進行熱切除，因此適合門診治療，並能快速復健。這項技術正被應用於日益超音波，包括局部前列腺癌的消融、子宮肌瘤的治療、經顱磁振造影（MRI）引導的聚焦超音波治療原發性顫抖和帕金森氏症等神經系統疾病、腫瘤消融，甚至包括皮膚緊緻等美容和皮膚科手術。市場涵蓋超音波導引和磁振造影導引系統、非侵入性和微創方法，以及包括醫院、門診手術中心、專科診所和研究機構在內的終端用戶。以 Sonablate、Focal One、Exablate 和 TULSA-PRO 等系統為核心的 HIFU 正在成為非侵入性圖像引導治療領域最有前途的新領域之一，其發展動力來自癌症發病率的上升、對器官保留療法的需求增加、向神經系統疾病領域的擴展以及保險報銷的改善。

高強度聚焦超音波（HIFU）市場的主要市場促進因素

  • 全球癌症負擔日益加重，推動了對非侵入性腫瘤消融的需求。國際癌症研究機構 (IARC) 預測，癌症患者人數將從 2022 年的 2,000 萬人增加到 2050 年的 3,500 萬人。
  • 人們越來越需要避免切口、電離輻射和傳統手術相關併發症的非侵入性、器官保留療法，這導致此類療法在包括腫瘤學在內的各種適應症中得到更廣泛的應用。
  • 該技術在神經病學領域的應用不斷擴展，包括磁振造影(MRI) 引導的聚焦超音波治療原發性顫抖和帕金森氏症，這為該技術開闢了新的高成長領域。
  • 一系列法規核准和認證，包括新型機器人前列腺 HIFU 系統和神經系統疾病適應症的批准和認證，正在擴大目標市場。
  • 保險報銷方面的改進，包括多個市場對磁振造影(MRI) 引導超音波超音波的有利保險覆蓋建議，正在推動其在臨床實踐中的應用。
  • 除了前列腺癌、子宮肌瘤和運動障礙的盛行率不斷上升之外，人口老化也擴大了可以接受治療的患者範圍。
  • 癌症發病率上升、對非侵入性治療的需求、向神經學領域的擴張以及監管和保險報銷方面的進步，預計到 2034 年將推動市場強勁成長。

高強度聚焦超音波（HIFU）市場的主要參與者

競爭格局主要由以下活躍的開發商和供應商推動：

  • Insightec Ltd.
  • EDAP TMS SA
  • Profound Medical Corp.
  • SonaCare Medical, LLC
  • 重慶海福醫療科技股份有限公司
  • Theraclion SA
  • Alpinion Medical Systems Co., Ltd.
  • Koninklijke Philips NV
  • FUSMobile Inc.
  • Arrayus Technologies Inc.

推動高強度聚焦超音波市場成長的因素

市場促進因素

全球癌症負擔日益加重，以及對腫瘤消融的需求不斷成長。

高強度聚焦超音波（HIFU）市場的主要驅動力是全球癌症負擔日益加重以及對非侵入性腫瘤消融的強勁需求。國際癌症研究機構（IARC）記錄顯示，2022年全球新增癌症病例達2000萬例，並預測到2050年這一數字將達到3500萬例，癌症仍將是全球主要死因之一。 HIFU無需切口即可達到腫瘤的精準熱消融。其在局部前列腺癌治療中尤其顯著，這種聚焦治療能夠在保留周圍組織的同時，破壞腫瘤或部分前列腺組織，從而減少根治性前列腺切除術和放射治療相關的尿失禁、勃起功能障礙和腸道併發症。此外，該技術也被應用於子宮肌瘤、肝癌、乳癌、胰臟癌、其他腫瘤，甚至骨轉移瘤的疼痛緩解治療。隨著人口老化和診斷技術的進步，癌症發生率不斷上升，患者和醫生越來越傾向於選擇器官保留療法，因此對使用 HIFU 進行腫瘤消融的需求不斷擴大，推動了整個預測期內的市場成長。

對非侵入性和器官保留療法的需求日益成長

對非侵入性和器官保留治療的需求日益成長，是其發展的核心驅動力。高強度聚焦超音波（HIFU）無需切口或電離輻射，即可透過皮膚和黏膜傳遞消融能量，因此適合門診治療，與傳統手術和放射療法相比，可實現更快的恢復、更少的出血和更低的併發症發生率。對於局限性前列腺癌，局部HIFU在保留泌尿和性功能方面遠優於治療整個前列腺。它還為子宮肌瘤和其他疾病提供了一種保留子宮的門診治療方案，可取代子宮切除術和開放性手術。患者越來越傾向於選擇能夠最大限度減少住院時間、疤痕和長期副作用的治療方法，而醫療系統也重視併發症減少和恢復更快而帶來的整體醫療成本降低。 HIFU的可重複性和高患者耐受性正在加速其在門診和護理機構的應用。隨著各專科對能夠維持生活品質 (QOL) 的微創治療的需求不斷成長，對 HIFU 的需求也在擴大，從而推動了預測期內的市場成長。

市場限制因素

儘管高強度聚焦超音波（HIFU）市場發展勢頭強勁，但仍面臨許多限制因素。 HIFU平台，尤其是需要使用磁振導航磁振造影，需要大量的資本投入和營運成本，導致系統和治療成本高昂，成為市場發展的主要障礙。這使得HIFU的應用僅限於資金雄厚的醫院和專業機構。雖然保險報銷情況正在改善，但在許多地區和適應症方面，報銷制度仍然不完善且不成熟，缺乏廣泛且一致的保險覆蓋範圍限制了患者的就醫機會和醫療機構的投資回報。某些應用，特別是某些磁振造影引導手術，治療時間較長，降低了處理能力，限制了每台設備可治療的患者數量。此外，還存在臨床和解剖學方面的限制。 HIFU並非適用於所有腫瘤部位或患者的解剖結構；患者的移動會影響標靶治療；某些組織和骨骼結構會阻礙能量傳遞。此外，對於某些適應症，與現有療法相比的長期療效數據仍在不斷改進。訓練有素的醫務人員和專業機構的短缺限制了治療能力，轉診醫生和患者的認知度也參差不齊。來自其他微創消融療法（例如冷凍療法、射頻消融術、立體定位放射療法以及新興的組織碎裂術）的競爭，正在加劇市場競爭。新適應症的法規核准流程漫長且需要大量證據。儘管市場對非侵入性治療的需求強勁且臨床應用不斷擴展，但成本、報銷、產能、臨床因素和認知度等方面的障礙共同作用，減緩了該領域的成長速度。

可以從以下幾個方面評估競爭格局：

  • 市場集中度：市場集中度適中，領導企業專注於特定應用，還有許多開發公司專注於特定地區或適應症。
  • 領先企業包括神經病學領域的 Insightec、前列腺領域的 EDAP TMS 和 SonaCare、經尿道磁振導航消融領域的 Profound Medical 以及腫瘤消融領域的重慶海福。
  • 地理分佈：每家公司均業務遍及北美、歐洲和亞太地區。重慶海福在中國擁有強大的市場地位，而Insightec和EDAP TMS則在全球建立了穩固的地位。
  • 產品系列優勢：我們的產品線涵蓋了前列腺、神經病學、子宮肌瘤、腫瘤消融和整形外科等領域的超音波導引和磁振導航平台。
  • 產品線和適應症拓展：在神經病學、前列腺全治療、靜脈曲張和腫瘤學領域正在進行的大型臨床試驗提供了決定性的競爭優勢。
  • 策略夥伴關係：我們透過與學術機構和影像合作夥伴（例如 Mayo Clinic 和 Insightec，以及 Siemens HealthIns 和 Sonablate）的合作，不斷擴大業務範圍。
  • 監管優勢：在治療前列腺、神經系統疾病和子宮肌瘤方面，公司已連續獲得 FDA 和國際批准，這是領先公司的關鍵差異化因素。
  • 保險報銷的進展：針對神經系統疾病的聚焦超音波療法的有利保險覆蓋建議以及針對局部治療的擴大保險覆蓋範圍，正在加強我們的市場地位。
  • 創新重點領域：機器人輔助聚焦治療、人工智慧驅動的目標選擇、即時溫度測量、影像融合、組織碎裂消融和神經調節治療。

高強度聚焦超音波市場報告要點

  • 對高強度聚焦超音波市場的當前市場規模（2025 年）進行分析，並進行 9 年市場預測（2026 年至 2034 年）。
  • 過去三年發生的重大產品和技術開發、合併、收購、合作和合資企業。
  • 全球聚焦超音波市場的領導者。
  • 高強度聚焦超音波市場為競爭者提供了各種機會。
  • 哪些細分市場在2025年表現最佳？這些細分市場在2034年的表現又會如何？
  • 在目前高強度聚焦超音波市場情勢下，哪些地區和國家表現最佳？
  • 企業應將精力集中在哪些地區或國家，以最大限度地抓住高強度聚焦超音波市場的未來成長機會？

本高強度聚焦超音波市場報告的主要讀者。

  • 高強度聚焦超音波（HIFU）產品供應商
  • 研究機構和顧問公司
  • 與高強度聚焦超音波（HIFU）相關的組織、協會、論壇和其他團體
  • 政府機構和公司
  • 新創公司、創業投資、私募股權公司
  • 銷售代理和經銷高強度聚焦超音波的公司。
  • 各種希望了解高強度聚焦超音波市場及其最新技術趨勢的終端用戶。

常問問題：

問題1：高強度聚焦超音波市場的成長率是多少？

預計從 2026 年到 2034 年的預測期內，高強度聚焦超音波市場將以 8.6% 的複合年成長率成長。

Q2.高強度聚焦超音波市場的市場規模有多大？

高強度聚焦超音波（HIFU）市場預計在 2025 年達到 14.5 億美元，預計到 2034 年將達到 30.5 億美元。

Q3. 哪個地區正在推動高強度聚焦超音波（HIFU）市場的發展？

由於先進的基礎設施、尖端技術的應用、神經系統和前列腺疾病治療保險覆蓋範圍的擴大，以及密集的治療中心和研發公司，預計北美主導高強度聚焦超音波市場，到2025年將佔全球銷售額的41%。亞太地區預計將成為預測期內成長最快的地區。

第四季：高強度聚焦超音波（HIFU）市場的主要市場促進因素是什麼？

主要的驅動力是全球癌症負擔日益加重。國際癌症研究機構（IARC）預測，癌症患者人數將從2022年的2,000萬人增加到2050年的3,500萬人。其他主要促進因素包括對非侵入性、器官超音波治療的需求不斷成長，磁振造影（MRI）引導聚焦超音波在神經系統疾病（例如用於治療原發性顫抖）中的應用日益廣泛，一系列法規核准的通過，以及保險報銷制度的改進。

Q5.高強度聚焦超音波（HIFU）市場的主要參與者有哪些？

主要公司包括Insightec Ltd.、EDAP TMS SA、Profound Medical Corp.、SonaCare Medical, LLC、重慶海福醫療科技有限公司、Theraclion SA、Alpinion Medical Systems Co., Ltd.、Koninklijke Philips NV、FUSMobile Inc.和Arrayus Technologies Inc.，以及「競爭格局」部分介紹的許多其他活躍供應商模式。 Insightec是神經病學領域的領導者，而EDAP TMS和SonaCare則是前列腺高強度聚焦超音波（HIFU）領域的領導者。

目錄

第1章：高強度聚焦超音波（HIFU）市場報告簡介

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章：高強度聚焦超音波（HIFU）市場執行摘要

  • 市場概覽

第3章：高強度聚焦超音波（HIFU）市場分析的關鍵因素

  • 高強度聚焦（ HIFU）市場：市場促進因素
    • 癌症負擔日益加重及腫瘤消融
    • 對非侵入性和器官保留治療的需求
    • 神經科學領域的應用不斷擴展
    • 監理機關核准和保險覆蓋範圍
  • 高強度聚焦超音波（HIFU）市場的市場限制與挑戰
    • 該系統和治療費用高昂。
    • 保險報銷和處理能力限制
    • 臨床限制和競爭格局
  • 高強度聚焦超音波（HIFU）市場：市場機遇
    • 神經病學、疼痛和血腦障壁的開放
    • 新興市場與新適應症

第4章 影響分析：人工智慧、地緣政治、貿易和經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：高強度聚焦超音波（HIFU）市場的波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的競爭

第7章：高強度聚焦超音波市場評估

  • 透過使用
    • 腫瘤學
    • 子宮肌瘤
    • 神經病變
    • 美容/皮膚科
    • 其他
  • 透過引導技術
    • 超音波引導高強度聚焦超音波
    • 磁振造影（MRI）引導下的高強度聚焦超音波（HIFU）
  • 透過方法
    • 非侵入性
    • 微創
  • 最終用戶
    • 醫院
    • 門診手術中心及專科診所
    • 診斷和影像中心
    • 研究機構
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：高強度聚焦超音波（HIFU）市場的競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章：高強度聚焦超音波（HIFU）市場的新創企業資金籌措與投資趨勢

第10章：高強度聚焦超音波（HIFU）市場：公司概況與產品概況

  • Insightec Ltd.
    • 公司簡介
    • 公司簡介
    • 財務概覽
    • 產品系列
    • 策略舉措/熵
  • EDAP TMS SA
  • Profound Medical Corp.
  • SonaCare Medical, LLC
  • Chongqing Haifu Medical Technology Co., Ltd.
  • Theraclion SA
  • Alpinion Medical Systems Co., Ltd.
  • Koninklijke Philips NV
  • FUSMobile Inc.
  • Arrayus Technologies Inc.

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0944

High-Intensity Focused Ultrasound Market Summary

Overview:

  • The High-Intensity Focused Ultrasound market is estimated at USD 1.45 billion in 2025 and is projected to reach USD 3.05 billion by 2034. Growth is anchored in the rising cancer burden, growing demand for non-invasive and incisionless therapy, and expanding clinical applications across prostate cancer, neurology, uterine fibroids, and aesthetics.
  • The global High-Intensity Focused Ultrasound market is growing at a CAGR of 8.6% during the forecast period from 2026 to 2034.
  • By application, the oncology segment dominated the High-Intensity Focused Ultrasound market with a 52% share in 2025.
  • By guidance technology, the ultrasound-guided HIFU segment dominated the High-Intensity Focused Ultrasound market with a 58% share in 2025.
  • By method, the non-invasive segment dominated the High-Intensity Focused Ultrasound market with a 74% share in 2025.
  • By end user, the hospitals segment dominated the High-Intensity Focused Ultrasound market with a 43% share in 2025.
  • North America dominated the global High-Intensity Focused Ultrasound market revenue with a 41% share in 2025, representing the highest regional market share globally.

High-intensity focused ultrasound (HIFU) is a non-invasive, incisionless therapeutic technology that focuses ultrasonic energy onto a targeted point deep within the body to raise tissue temperature and precisely ablate diseased tissue while sparing surrounding structures. Guided in real time by either ultrasound imaging or magnetic resonance imaging, HIFU delivers thermal ablation without incisions or ionizing radiation, enabling outpatient treatment with rapid recovery. The technology is used across a widening range of clinical applications, including focal ablation of localized prostate cancer, treatment of uterine fibroids, neurological indications such as essential tremor and Parkinson's disease through transcranial magnetic-resonance-guided focused ultrasound, tumor ablation, and aesthetic and dermatological procedures such as skin tightening. The market spans ultrasound-guided and magnetic-resonance-guided systems, non-invasive and minimally invasive approaches, and end users including hospitals, ambulatory surgical centers, specialty clinics, and research institutes. Anchored by systems such as Sonablate, Focal One, Exablate, and TULSA-PRO, and propelled by the rising cancer burden, demand for organ-sparing therapy, neurological expansion, and improving reimbursement, HIFU has emerged as one of the most promising frontiers in non-invasive, image-guided therapeutics.

High-Intensity Focused Ultrasound Market Key Growth Drivers

  • The rising global cancer burden is driving demand for non-invasive tumor ablation, with the International Agency for Research on Cancer projecting cancer cases to rise from 20 million in 2022 to 35 million by 2050.
  • Growing demand for non-invasive and organ-sparing therapy, which avoids incisions, ionizing radiation, and the morbidity of conventional surgery, is expanding adoption across oncology and other indications.
  • Expanding neurological applications, including magnetic-resonance-guided focused ultrasound for essential tremor and Parkinson's disease, are opening a high-growth frontier for the technology.
  • A wave of regulatory clearances and approvals, including new editions of robotic prostate HIFU systems and neurological indications, is broadening the addressable market.
  • Improving reimbursement, including favorable coverage recommendations for magnetic-resonance-guided focused ultrasound in several markets, is supporting clinical adoption.
  • Rising prevalence of prostate cancer, uterine fibroids, and movement disorders, alongside aging populations, is enlarging the treatable patient pool.
  • The convergence of cancer burden, non-invasive therapy demand, neurological expansion, and regulatory and reimbursement progress is expected to sustain strong growth in the market through 2034.

Key Companies in High-Intensity Focused Ultrasound Market

The competitive landscape is led by the following active developers and providers:

  • Insightec Ltd.
  • EDAP TMS S.A.
  • Profound Medical Corp.
  • SonaCare Medical, LLC
  • Chongqing Haifu Medical Technology Co., Ltd.
  • Theraclion S.A.
  • Alpinion Medical Systems Co., Ltd.
  • Koninklijke Philips N.V.
  • FUSMobile Inc.
  • Arrayus Technologies Inc.

Factors Contributing to the Growth of the High-Intensity Focused Ultrasound Market

Market Drivers

Rising Global Cancer Burden and Demand for Tumor Ablation

The most powerful driver of the HIFU market is the rising global cancer burden and the strong demand for non-invasive tumor ablation. The International Agency for Research on Cancer recorded 20 million new cancer cases in 2022 and projects 35 million by 2050, and cancer remains a leading cause of death worldwide. HIFU offers precise, incisionless thermal ablation of tumors, most prominently in localized prostate cancer, where focal therapy can destroy either the tumor or a portion of the gland while sparing surrounding tissue, reducing the incontinence, erectile dysfunction, and bowel morbidity associated with whole-gland surgery or radiation. The technology is also applied to uterine fibroids, liver, breast, pancreatic, and other tumors, and to bone metastases for pain palliation. As cancer incidence climbs with aging populations and improving diagnosis, and as patients and physicians increasingly favor organ-sparing options, demand for HIFU tumor ablation expands, anchoring market growth through the forecast period.

Growing Demand for Non-Invasive and Organ-Sparing Therapy

Growing demand for non-invasive, organ-sparing therapy is a central growth engine. HIFU delivers ablative energy through the skin and mucosa without incisions or ionizing radiation, enabling outpatient treatment, rapid recovery, minimal blood loss, and low complication rates compared with conventional surgery and radiotherapy. For localized prostate cancer, focal HIFU preserves continence and potency far better than whole-gland treatment, and for uterine fibroids and other conditions it offers a uterus-sparing, day-case alternative to hysterectomy or open surgery. Patients increasingly seek treatments that minimize hospitalization, scarring, and long-term side effects, and health systems value the reduced complications and faster recovery that lower overall care costs. The repeatable and well-tolerated nature of HIFU supports its integration into outpatient and ambulatory settings. As preference for minimally invasive, quality-of-life-preserving therapy grows across specialties, demand for HIFU expands, reinforcing market growth across the forecast period.

Market Restraints

Despite strong momentum, the HIFU market faces material constraints. High system and procedure costs are a primary barrier, as HIFU platforms, particularly magnetic-resonance-guided systems that require access to magnetic resonance imaging suites, involve substantial capital investment and operating expense, limiting adoption to well-resourced hospitals and specialized centers. Reimbursement, although improving, remains uneven and immature across many geographies and indications, and the absence of broad or consistent coverage constrains patient access and the return on investment for providers. Long treatment times for certain applications, particularly some magnetic-resonance-guided procedures, reduce throughput and limit the number of patients treated per system. Clinical and anatomical limitations also apply, as HIFU is not suitable for all tumor locations or patient anatomies, patient movement can affect targeting, and some tissues and bony structures impede energy delivery, while long-term comparative outcomes data against established therapies are still maturing for several indications. A shortage of trained operators and specialized centers limits capacity, and awareness among referring physicians and patients remains uneven. Competition from other minimally invasive and ablative modalities, including cryotherapy, radiofrequency ablation, stereotactic radiotherapy, and emerging histotripsy, intensifies the landscape. Regulatory pathways for new indications are lengthy and evidence-intensive. Together, these cost, reimbursement, throughput, clinical, and awareness barriers temper the pace of growth, even as the underlying drivers of non-invasive therapy demand and clinical expansion remain firmly intact.

High-Intensity Focused Ultrasound Market Segment Analysis

The High-Intensity Focused Ultrasound Market by Application (Oncology, Uterine Fibroids, Neurological Disorders, Aesthetics and Dermatology, Others), Guidance Technology (Ultrasound-Guided HIFU, Magnetic-Resonance-Guided HIFU), Method (Non-Invasive, Minimally Invasive), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics, Diagnostic and Imaging Centers, Research Institutes), and Geography (North America, Europe, Asia-Pacific, Rest of World).

By Application

Dominant Subsegment: Oncology. The oncology category is expected to dominate the market.

Dominant: Oncology ~ 52%

The oncology segment accounted for 52% of the High-Intensity Focused Ultrasound market in 2025. Oncology is the leading application because HIFU's core clinical value lies in the non-invasive, organ-sparing ablation of tumors, most prominently localized prostate cancer. Focal HIFU destroys the tumor or a portion of the prostate while preserving continence and potency far better than whole-gland surgery or radiation, and dedicated systems such as Sonablate, Focal One, Exablate Prostate, and TULSA-PRO anchor a large and growing prostate-cancer segment. Beyond the prostate, HIFU ablates liver, breast, pancreatic, kidney, and other tumors and palliates bone-metastasis pain, broadening its oncology footprint. The rising global cancer burden, growing preference for organ-sparing therapy, and expanding clinical evidence reinforce the segment's dominance. Neurological disorders form the fastest-growing application, while uterine fibroids and aesthetic and dermatological procedures are large and established segments. Nonetheless, the scale, clinical value, and breadth of tumor-ablation applications secure the leadership of oncology across the forecast period.

By Guidance Technology

Dominant Subsegment: Ultrasound-Guided HIFU. The ultrasound-guided HIFU category is expected to dominate the market.

Dominant: Ultrasound-Guided HIFU ~ 58%

The ultrasound-guided HIFU segment accounted for 58% of the High-Intensity Focused Ultrasound market in 2025. Ultrasound-guided HIFU is the leading guidance technology because it is more widely deployed, more affordable, and more accessible than magnetic-resonance-guided systems, which require costly access to magnetic resonance imaging suites. Ultrasound guidance provides real-time imaging integrated directly into the treatment system, enabling efficient, lower-cost procedures in urology, gynecology, and general tumor ablation, and it underpins widely used prostate systems such as Sonablate and Focal One as well as many fibroid and tumor-ablation platforms. Its lower capital and operating costs support broader adoption across hospitals, ambulatory centers, and clinics. Magnetic-resonance-guided HIFU is a large and fast-growing segment, essential for neurological applications and valued for superior soft-tissue visualization and real-time thermometry, exemplified by Exablate Neuro and TULSA-PRO. While magnetic-resonance-guided systems grow rapidly in neurology, the accessibility, affordability, and installed base of ultrasound-guided HIFU secure its leadership across the forecast period.

By End User

Dominant Subsegment: Hospitals. The hospitals category is expected to dominate the market.

Dominant: Hospitals ~ 43%

The hospitals segment accounted for 43% of the High-Intensity Focused Ultrasound market in 2025. Hospitals are the leading end user because HIFU systems, particularly magnetic-resonance-guided platforms, require substantial capital investment, specialized infrastructure, and multidisciplinary teams that large hospitals and academic medical centers are best positioned to provide. Hospitals treat the most complex cases across urology, neurology, and gynecology, integrate HIFU into comprehensive cancer and neurology programs, and serve as the primary sites for new indications and clinical studies, anchoring their large share. Leading institutions adopt HIFU to differentiate their offerings and meet patient demand for non-invasive options. Ambulatory surgical centers and specialty clinics form a large and fast-growing segment, particularly for prostate focal therapy and aesthetic procedures that suit outpatient, lower-cost settings, while diagnostic and imaging centers and research institutes support magnetic-resonance-guided treatment and clinical development. While ambulatory and specialty settings grow quickly, the infrastructure, case complexity, and clinical breadth of hospitals secure their leadership across the forecast period.

High-Intensity Focused Ultrasound Market Region Analysis

Dominant Region: North America

North America accounted for 41% of the global High-Intensity Focused Ultrasound market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced healthcare infrastructure, high adoption of innovative medical technology, strong reimbursement momentum for neurological and prostate applications, and the presence of leading HIFU developers and treatment centers, particularly in the United States. North America leads in magnetic-resonance-guided focused ultrasound for essential tremor and Parkinson's disease, in robotic focal prostate therapy with systems such as Focal One and Sonablate, and in clinical research expanding HIFU into new indications. The region benefits from high healthcare spending, a large base of academic medical centers and specialized treatment sites, active clinical trials, and growing payer coverage. Strong infrastructure, technology adoption, and reimbursement progress anchor the region's continued leadership across the forecast period.

Dominant: North America ~ 41% (Largest)

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the High-Intensity Focused Ultrasound market. The region's elevated CAGR is driven by a large and rising cancer burden, expanding healthcare access and investment, growing adoption of non-invasive therapy, and strong regional developers across China, Japan, South Korea, and India. China is a major center of HIFU innovation and use, home to Chongqing Haifu Medical Technology, a pioneer of ultrasound-guided HIFU for tumor ablation, and the region benefits from large patient populations, government investment in advanced healthcare, and expanding treatment capacity. Rising prostate cancer and uterine fibroid prevalence, growing neurological application, and increasing adoption of aesthetic HIFU further accelerate demand. The combination of high disease burden, healthcare investment, and local innovation positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 41% of the global High-Intensity Focused Ultrasound market revenue in 2025. The United States dominates on the strength of advanced infrastructure, high technology adoption, growing reimbursement for neurological and prostate applications, a dense base of treatment centers, and active clinical research, while Canada contributes through neurological and prostate HIFU adoption and the presence of Profound Medical.

Europe

Europe is a large and advanced regional market, led by Germany, the United Kingdom, France, Italy, and Spain. Growth is supported by strong adoption of focal prostate therapy and neurological focused ultrasound, active clinical research, the presence of developers such as EDAP TMS and Theraclion, and expanding reimbursement, including favorable coverage recommendations for magnetic-resonance-guided focused ultrasound in several countries.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by a large and rising cancer burden, expanding healthcare access and investment, and strong regional developers across China, Japan, South Korea, and India. Chongqing Haifu anchors ultrasound-guided tumor ablation, while growing prostate, fibroid, neurological, and aesthetic applications and large patient populations broaden adoption across the region.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging contributor. Rising cancer and chronic-disease burden, growing interest in non-invasive therapy, and adoption of prostate and aesthetic HIFU in premium private centers, particularly in the Gulf states, are creating early demand, while broader adoption awaits stronger reimbursement, infrastructure, and trained-operator capacity across these markets over the forecast period.

High-Intensity Focused Ultrasound Market Competitive Landscape

The High-Intensity Focused Ultrasound market is classified as Moderately Concentrated. A group of specialized leaders, including Insightec, EDAP TMS, Profound Medical, SonaCare Medical, and Chongqing Haifu, holds a substantial share across the principal application areas of neurology, prostate, and tumor ablation, while a broad field of regional and application-focused developers, including Theraclion, Alpinion, FUSMobile, Arrayus, and aesthetic-HIFU providers, competes across indications and geographies, keeping the market competitive and innovation-driven.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Moderately concentrated, with application-specialized leaders alongside a broad field of regional and indication-focused developers.
  • Leading players: Insightec leads neurology, EDAP TMS and SonaCare lead prostate, Profound Medical leads transurethral MR-guided ablation, and Chongqing Haifu leads tumor ablation.
  • Geographic reach: Players span North America, Europe, and Asia-Pacific, with Chongqing Haifu strong in China and Insightec and EDAP TMS globally established.
  • Product portfolio strength: Systems span ultrasound-guided and magnetic-resonance-guided platforms across prostate, neurology, fibroids, tumor ablation, and aesthetics.
  • Pipeline and indication expansion: Ongoing pivotal studies in neurology, whole-gland prostate treatment, varicose veins, and oncology are decisive competitive assets.
  • Strategic partnerships: Collaborations with academic centers and imaging partners, such as Insightec with Mayo Clinic and Sonablate with Siemens Healthineers, extend reach.
  • Regulatory strength: Successive FDA and international clearances across prostate, neurological, and fibroid indications differentiate leading players.
  • Reimbursement progress: Favorable coverage recommendations for neurological focused ultrasound and growing focal-prostate coverage strengthen commercial positioning.
  • Innovation focus: Robotic focal therapy, AI-assisted targeting, real-time thermometry, imaging fusion, histotripsy-adjacent ablation, and neuromodulation.

High-Intensity Focused Ultrasound Market Recent Developmental Activities

In November 2025, EDAP TMS S.A., received FDA 510(k) clearance for the latest edition of its Focal One Robotic HIFU system, adding advanced ultrasound imaging, streamlined treatment planning, an optimized user interface, and support for artificial-intelligence-driven ablation-visualization algorithms. Strategic significance: Strengthened EDAP's leadership in robotic focal prostate therapy and advanced AI-assisted HIFU.

In 2025, EDAP TMS S.A., launched the Focal One i at the American Urological Association Annual Meeting, integrating enhanced imaging and workflow capabilities for robotic focal prostate cancer therapy. Strategic significance: Refreshed EDAP's flagship platform and reinforced its position in ultrasound-guided prostate HIFU.

High-Intensity Focused Ultrasound Market Segmentation

High-Intensity Focused Ultrasound Market by Application

  • Oncology
  • Prostate Cancer
  • Liver, Breast, and Pancreatic Tumors
  • Bone Metastasis Palliation
  • Other Tumors
  • Uterine Fibroids
  • Neurological Disorders
  • Aesthetics and Dermatology
  • Others

High-Intensity Focused Ultrasound Market by Guidance Technology

  • Ultrasound-Guided HIFU (USgHIFU)
  • Magnetic-Resonance-Guided HIFU (MRgHIFU)

High-Intensity Focused Ultrasound Market by Method

  • Non-Invasive
  • Minimally Invasive

High-Intensity Focused Ultrasound Market by End User

  • Hospitals
  • Ambulatory Surgical Centers and Specialty Clinics
  • Diagnostic and Imaging Centers
  • Research Institutes

High-Intensity Focused Ultrasound Market by Geography

  • North America High-Intensity Focused Ultrasound Market
  • United States High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Canada High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Mexico High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Europe High-Intensity Focused Ultrasound Market
  • Germany High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • United Kingdom High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • France High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Italy High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Spain High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Rest of Europe High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Asia-Pacific High-Intensity Focused Ultrasound Market
  • China High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Japan High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • India High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • South Korea High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Australia High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Rest of the World (RoW) High-Intensity Focused Ultrasound Market
  • Middle East High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • Africa High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
  • South America High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)

Key Takeaways from the High-Intensity Focused Ultrasound Market Report Study

  • Market size analysis for the current high-intensity focused ultrasound market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global high-intensity focused ultrasound market.
  • Various opportunities available for competitors in the high-intensity focused ultrasound market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current high-intensity focused ultrasound market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for high-intensity focused ultrasound market growth in the future?

Target audience who can benefit from this high-intensity focused ultrasound market report study

  • High-Intensity Focused Ultrasound product providers
  • Research organizations and consulting companies
  • High-Intensity Focused Ultrasound-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in high-intensity focused ultrasound
  • Various end-users who want to know more about the high-intensity focused ultrasound market and the latest technological developments in the high-intensity focused ultrasound market.

Frequently Asked Questions:

Q1. What is the growth rate of the High-Intensity Focused Ultrasound market?

The High-Intensity Focused Ultrasound market is projected to expand at a CAGR of 8.6% during the forecast period from 2026-2034.

Q2. What is the market size of the High-Intensity Focused Ultrasound market?

The High-Intensity Focused Ultrasound market is estimated at USD 1.45 billion in 2025 and is projected to reach USD 3.05 billion by 2034.

Q3. Which region dominates the High-Intensity Focused Ultrasound market?

North America dominated the High-Intensity Focused Ultrasound market with a 41% share of global revenue in 2025, supported by advanced infrastructure, high technology adoption, growing reimbursement for neurological and prostate applications, and a dense base of treatment centers and developers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the High-Intensity Focused Ultrasound market?

The principal drivers are the rising global cancer burden, with the International Agency for Research on Cancer projecting cancer cases to rise from 20 million in 2022 to 35 million by 2050; growing demand for non-invasive, organ-sparing therapy; expanding neurological applications such as magnetic-resonance-guided focused ultrasound for essential tremor; a wave of regulatory clearances; and improving reimbursement.

Q5. Who are the major players in the High-Intensity Focused Ultrasound market?

The major players include Insightec Ltd., EDAP TMS S.A., Profound Medical Corp., SonaCare Medical, LLC, Chongqing Haifu Medical Technology Co., Ltd., Theraclion S.A., Alpinion Medical Systems Co., Ltd., Koninklijke Philips N.V., FUSMobile Inc., and Arrayus Technologies Inc., among other active providers profiled in the Competitive Landscape section. Insightec leads neurology, while EDAP TMS and SonaCare lead prostate HIFU.

Table of Contents

1. High-Intensity Focused Ultrasound Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. High-Intensity Focused Ultrasound Market Executive Summary

  • 2.1 Market at a Glance

3. High-Intensity Focused Ultrasound Market Key Factors Analysis

  • 3.1 High-Intensity Focused Ultrasound Market Drivers
    • 3.1.1 Rising Cancer Burden and Tumor Ablation
    • 3.1.2 Demand for Non-Invasive, Organ-Sparing Therapy
    • 3.1.3 Expanding Neurological Applications
    • 3.1.4 Regulatory Clearances and Reimbursement
  • 3.2 High-Intensity Focused Ultrasound Market Restraints and Challenges
    • 3.2.1 High System and Procedure Costs
    • 3.2.2 Reimbursement and Throughput Limits
    • 3.2.3 Clinical Limitations and Competition
  • 3.3 High-Intensity Focused Ultrasound Market Opportunities
    • 3.3.1 Neurology, Pain, and Blood-Brain-Barrier Opening
    • 3.3.2 Emerging Markets and New Indications

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. High-Intensity Focused Ultrasound Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. High-Intensity Focused Ultrasound Market Assessment

  • 7.1 By Application
    • 7.1.1 Oncology
    • 7.1.2 Uterine Fibroids
    • 7.1.3 Neurological Disorders
    • 7.1.4 Aesthetics and Dermatology
    • 7.1.5 Others
  • 7.2 By Guidance Technology
    • 7.2.1 Ultrasound-Guided HIFU
    • 7.2.2 Magnetic-Resonance-Guided HIFU
  • 7.3 By Method
    • 7.3.1 Non-Invasive
    • 7.3.2 Minimally Invasive
  • 7.4 By End User
    • 7.4.1 Hospitals
    • 7.4.2 Ambulatory Surgical Centers and Specialty Clinics
    • 7.4.3 Diagnostic and Imaging Centers
    • 7.4.4 Research Institutes
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.1.2 Canada High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.1.3 Mexico High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
    • 7.5.2 Europe
      • 7.5.2.1 Germany High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.2.2 United Kingdom High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.2.3 France High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.2.4 Italy High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.2.5 Spain High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.2.6 Rest of Europe High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.3.2 Japan High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.3.3 India High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.3.4 South Korea High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.3.5 Australia High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.3.6 Rest of Asia-Pacific High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
    • 7.5.4 Rest of World
      • 7.5.4.1 Middle East High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.4.2 Africa High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)
      • 7.5.4.3 South America High-Intensity Focused Ultrasound Market Size in USD million (2023-2034)

8. High-Intensity Focused Ultrasound Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. High-Intensity Focused Ultrasound Market Startup Funding and Investment Trends

10. High-Intensity Focused Ultrasound Market Company and Product Profiles

  • 10.1 Insightec Ltd.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 EDAP TMS S.A.
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 Profound Medical Corp.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 SonaCare Medical, LLC
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 Chongqing Haifu Medical Technology Co., Ltd.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 Theraclion S.A.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 Alpinion Medical Systems Co., Ltd.
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 Koninklijke Philips N.V.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 FUSMobile Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 Arrayus Technologies Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: High-Intensity Focused Ultrasound Market in Global (2023-2034)
  • Table 2: High-Intensity Focused Ultrasound Market in Global by Application (2023-2034)
  • Table 3: High-Intensity Focused Ultrasound Market in Global by Guidance Technology (2023-2034)
  • Table 4: High-Intensity Focused Ultrasound Market in Global by Method (2023-2034)
  • Table 5: High-Intensity Focused Ultrasound Market in Global by End User (2023-2034)
  • Table 6: High-Intensity Focused Ultrasound Market in Global by Geography (2023-2034)
  • Table 7: High-Intensity Focused Ultrasound Market in North America (2023-2034)
  • Table 8: High-Intensity Focused Ultrasound Market in the United States (2023-2034)
  • Table 9: High-Intensity Focused Ultrasound Market in Canada (2023-2034)
  • Table 10: High-Intensity Focused Ultrasound Market in Mexico (2023-2034)
  • Table 11: High-Intensity Focused Ultrasound Market in Europe (2023-2034)
  • Table 12: High-Intensity Focused Ultrasound Market in Germany (2023-2034)
  • Table 13: High-Intensity Focused Ultrasound Market in United Kingdom (2023-2034)
  • Table 14: High-Intensity Focused Ultrasound Market in France (2023-2034)
  • Table 15: High-Intensity Focused Ultrasound Market in Italy (2023-2034)
  • Table 16: High-Intensity Focused Ultrasound Market in Spain (2023-2034)
  • Table 17: High-Intensity Focused Ultrasound Market in the Rest of Europe (2023-2034)
  • Table 18: High-Intensity Focused Ultrasound Market in Asia-Pacific (2023-2034)
  • Table 19: High-Intensity Focused Ultrasound Market in China (2023-2034)
  • Table 20: High-Intensity Focused Ultrasound Market in Japan (2023-2034)
  • Table 21: High-Intensity Focused Ultrasound Market in India (2023-2034)
  • Table 22: High-Intensity Focused Ultrasound Market in South Korea (2023-2034)
  • Table 23: High-Intensity Focused Ultrasound Market in Australia (2023-2034)
  • Table 24: High-Intensity Focused Ultrasound Market in Rest of Asia-Pacific (2023-2034)
  • Table 25: High-Intensity Focused Ultrasound Market in the Rest of the World (2023-2034)
  • Table 26: High-Intensity Focused Ultrasound Market in the Middle East (2023-2034)
  • Table 27: High-Intensity Focused Ultrasound Market in Africa (2023-2034)
  • Table 28: High-Intensity Focused Ultrasound Market in South America (2023-2034)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding and Investment Trends

List of Figures

  • Figure 1: High-Intensity Focused Ultrasound Market Drivers
  • Figure 2: High-Intensity Focused Ultrasound Market Restraints
  • Figure 3: High-Intensity Focused Ultrasound Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: High-Intensity Focused Ultrasound Market in Global (2023-2034)
  • Figure 9: High-Intensity Focused Ultrasound Market in Global by Application (2023-2034)
  • Figure 10: High-Intensity Focused Ultrasound Market in Global by Guidance Technology (2023-2034)
  • Figure 11: High-Intensity Focused Ultrasound Market in Global by Method (2023-2034)
  • Figure 12: High-Intensity Focused Ultrasound Market in Global by End User (2023-2034)
  • Figure 13: High-Intensity Focused Ultrasound Market in Global by Geography (2023-2034)
  • Figure 14: High-Intensity Focused Ultrasound Market in North America (2023-2034)
  • Figure 15: High-Intensity Focused Ultrasound Market in the United States (2023-2034)
  • Figure 16: High-Intensity Focused Ultrasound Market in Canada (2023-2034)
  • Figure 17: High-Intensity Focused Ultrasound Market in Mexico (2023-2034)
  • Figure 18: High-Intensity Focused Ultrasound Market in Europe (2023-2034)
  • Figure 19: High-Intensity Focused Ultrasound Market in Germany (2023-2034)
  • Figure 20: High-Intensity Focused Ultrasound Market in United Kingdom (2023-2034)
  • Figure 21: High-Intensity Focused Ultrasound Market in France (2023-2034)
  • Figure 22: High-Intensity Focused Ultrasound Market in Italy (2023-2034)
  • Figure 23: High-Intensity Focused Ultrasound Market in Spain (2023-2034)
  • Figure 24: High-Intensity Focused Ultrasound Market in the Rest of Europe (2023-2034)
  • Figure 25: High-Intensity Focused Ultrasound Market in Asia-Pacific (2023-2034)
  • Figure 26: High-Intensity Focused Ultrasound Market in China (2023-2034)
  • Figure 27: High-Intensity Focused Ultrasound Market in Japan (2023-2034)
  • Figure 28: High-Intensity Focused Ultrasound Market in India (2023-2034)
  • Figure 29: High-Intensity Focused Ultrasound Market in South Korea (2023-2034)
  • Figure 30: High-Intensity Focused Ultrasound Market in Australia (2023-2034)
  • Figure 31: High-Intensity Focused Ultrasound Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: High-Intensity Focused Ultrasound Market in the Rest of the World (2023-2034)
  • Figure 33: High-Intensity Focused Ultrasound Market in the Middle East (2023-2034)
  • Figure 34: High-Intensity Focused Ultrasound Market in Africa (2023-2034)
  • Figure 35: High-Intensity Focused Ultrasound Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding and Investment Trends